Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
about
Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and EThe varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent mannerMurine gammaherpesvirus 68 encodes a functional regulator of complement activationCoagulation initiated on herpesviruses.In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivovLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus.Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and diseaseHSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins.Complement and viral pathogenesisA limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous systemHerpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.Herpes simplex virus type 1 evades the effects of antibody and complement in vivoHerpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humansO-linked glycosylation of the mucin domain of the herpes simplex virus type 1-specific glycoprotein gC-1 is temporally regulated in a seed-and-spread mannerExperimental investigation of herpes simplex virus latencyImmune evasion by herpes simplex virus type 1, strategies for virus survivalIn vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gCBlocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infectionEngineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectorsAn HSV-1 gD mutant virus as an entry-impaired live virus vaccine.Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccineHerpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.Virus inhibition of RIP3-dependent necrosis.Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding.Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132.Structural rearrangement within an enveloped virus upon binding to the host cell.DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis.Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack.
P2860
Q24646778-4C82589B-ADF3-45F9-A9AB-13468A3012A3Q33304402-CD746414-EF60-490A-BA0C-2AD64C09D33BQ33650182-1EA7E912-5F11-4DD1-8DD8-4E4BA34B4D33Q33709008-1540F746-E14A-4D28-B266-CEA42262D240Q33784845-6526FAE9-9361-4125-AC33-67358DBA5B75Q33784923-349AC34D-EC80-4847-9534-F1018452ABB9Q33788825-DCB73059-99DF-4EEB-BEC6-163BCAD280C6Q33804845-E115E0E6-67B4-4619-9AD9-0A4BA7A3E516Q33808376-AF07DBCE-A787-4BAE-B200-3CBDF4493DB8Q33995747-2E2C9D51-B7A0-433D-8452-EC578C30BAC0Q34092761-AA0E1268-0CE3-4418-B033-4F5259FCF47CQ34162421-FDB550B6-36D2-42CB-9B2F-B5916E2E0B3BQ34286445-70917930-3D9D-4946-A850-F0CB1104A5C1Q34335296-FCFF12C1-61E8-4F0A-87E9-3DC398DCEED3Q34345831-036F1276-C3F0-4107-AE5E-94CDC3EE8FAAQ34545821-A59681F7-2042-4044-A8F1-B1E248D0D8A8Q34593833-DA306341-39B0-47CA-B067-3A3BDE2EB7ABQ35104007-BCED5BF2-1E32-4F8B-88D4-1B3505CE032AQ35374610-7FA0503F-768E-4D9B-B8DA-5002265505DCQ36372405-DF13D1BD-8CED-489B-9513-632DCB23C869Q36375668-5FB575F0-DB7A-446B-8CAE-C619F5AE591DQ37060288-F87575F4-122C-4941-9501-E5705919357BQ37075772-263ED626-6C57-4399-9F77-75DFCE05C45DQ37188380-B629ED1F-2F41-4074-9206-C8AE3DE81BAEQ37439603-845B16DB-D708-4D70-ACD5-F01792A24E97Q37456642-6EC3D2A7-AA11-42FB-9416-BB90EE742E63Q38646953-C0B507D0-1876-44EA-8EFC-B2492BA79CC2Q39711744-AE52DD21-54C6-4BF3-BA05-81FF53FDDB3CQ41873760-356CB3B4-12EF-4105-8DA3-DC4E6E831035Q42737597-EE4D1DB4-BFDD-4B40-955A-1880FE60FCC1Q43007482-BB316AF3-BACC-455E-9382-5E24F8282795Q45324169-B413A775-4122-4059-87A5-28F4738635B1Q45731866-34A62728-C91F-4094-84D5-5D42DC0D1F8A
P2860
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
@ast
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
@en
type
label
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
@ast
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
@en
prefLabel
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
@ast
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
@en
P2093
P2860
P1433
P1476
Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.
@en
P2093
H M Friedman
J D Lambris
J Lubinski
N O Fishman
R J Eisenberg
P2860
P304
P407
P577
1996-07-01T00:00:00Z